Harpagosides and Vitamin D Composition for Osteoarthritis Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammation, such as steroidal and non-steroidal anti-inflammatory drugs, often cause severe side effects and are not well-tolerated, while existing plant-based compositions may not effectively address chronic inflammation and joint pain associated with conditions like osteoarthritis.
Innovation Solution
A novel composition combining Devil's Claw (Harpagophytum) extract, specifically harpagosides, with vitamin D, which acts synergistically to provide anti-inflammatory effects, reducing pain and inflammation without the severe side effects of conventional treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroidal or non-steroidal anti-inflammatory drugs are used to treat inflammation, then inflammatory symptoms are reduced, but severe side effects occur such as digestive bleeding, ulcers, kidney failure, and metabolic disorders
Solution Approach 1:
The patent changes the chemical composition parameters by using plant-based compounds (harpagosides, beta-sitosterol, flavonoids, phenolic acids, quinones) instead of steroidal or non-steroidal anti-inflammatory drugs. This parameter change maintains anti-inflammatory efficacy while reducing harmful side effects through the natural origin and multi-component composition of the plant extract
Solution Approach 2:
The patent employs a composite composition containing multiple active principles from Harpagophytum (harpagosides, beta-sitosterol, flavonoids, phenolic acids, quinones) that work synergistically. This composite approach provides anti-inflammatory effects through multiple mechanisms simultaneously, reducing reliance on single-compound drugs that cause severe side effects
2Object-affected harmful factors
If plant-based compositions are used to treat inflammation, then side effects are reduced, but efficacy for chronic inflammation and joint pain may be insufficient
Solution Approach 1:
The patent combines multiple active principles from Harpagophytum (harpagosides, beta-sitosterol, flavonoids, phenolic acids, quinones) into a single composition that acts synergistically on multiple physiological targets. This merging of multiple plant-based compounds enhances anti-inflammatory efficacy for chronic conditions while maintaining the safety profile of plant-derived substances
Solution Approach 2:
The patent creates a multi-functional composition where Harpagophytum extract simultaneously provides anti-inflammatory, analgesic, and protective effects through its various active components. The composition targets multiple pathways involved in chronic inflammation and joint pain, making it effective for various inflammatory conditions including osteoarthritis and rheumatoid arthritis
Data Source
AI summary
Composition comprises Harpagophytum(50-3000 mg) or harpagosides (1-100 mg) and vitamin D (0.5-50 mu g). ACTIVITY : Anabolic; Antiinflammatory; Analgesic; Antiarthritic; Osteopathic; Antiasthmatic; Antiarteriosclerotic; Antirheumatic; Antiallergic; Dermatological; Antipsoriatic; CNS-Gen.; Respiratory-Gen.; Neuroprotective; Antidiabetic; Vasotropic; Nephrotropic; Ophthalmological; Antipyretic; Immunosuppressive; Muscular-Gen.; Antigout. MECHANISM OF ACTION : None given.